Gene therapies for osteoarthritis: progress and prospects
Introduction: Osteoarthritis (OA), the most common form of joint disease, affects more than 500 million people worldwide. This painful and debilitating disease imposes a huge socioeconomic cost worldwide. Despite years of promising research, no etiological drug has been successfully introduced into...
Saved in:
Main Authors: | Anais Defois (Author), Nina Bon (Author), Mathieu Mével (Author), David Deniaud (Author), Yves Maugars (Author), Jérôme Guicheux (Author), Oumeya Adjali (Author), Claire Vinatier (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPARβ/δ-Interfering Peptide Enhanced Mesenchymal Stromal Cell Immunoregulatory Properties
by: Gautier Tejedor, et al.
Published: (2022) -
Gene therapies development: slow progress and promising prospect
by: Eve Hanna, et al.
Published: (2017) -
Phosphate-dependent FGF23 secretion is modulated by PiT2/Slc20a2
by: Nina Bon, et al.
Published: (2018) -
Polysaccharide Hydrogels Support the Long-Term Viability of Encapsulated Human Mesenchymal Stem Cells and Their Ability to Secrete Immunomodulatory Factors
by: Fahd Hached, et al.
Published: (2017) -
Perspective in Progress of Cardiovascular Gene Therapy
by: Ryuichi Morishita
Published: (2004)